Management of Spastic Paraparesis

Initial Non-Pharmacological Management

The American Heart Association recommends initiating range-of-motion exercises immediately to prevent contracture progression, performing them several times daily in all patients with spastic paraparesis 1, 2
Implementing antispastic positioning and proper body alignment is crucial to reduce reflex hyperexcitability and prevent fixed contractures, as suggested by the American Stroke Association 1, 2
Applying stretching programs and splinting is essential to maintain joint mobility, with serial casting for established contractures that interfere with function, according to the American Heart Association 1, 2
Consider surgical correction for severe contractures that restrict movement or cause pain and impede rehabilitation, as recommended by the American Academy of Neurology 1, 2

The American Academy of Neurology recommends baclofen as the preferred first-line oral agent for spasticity, particularly effective for flexor spasms and concomitant pain in spinal cord-related spasticity 3, 5
Tizanidine is specifically recommended for chronic stroke patients and is FDA-approved for spasticity management, according to the American Heart Association 1, 2
Dantrolene is an alternative oral agent for generalized spasticity, as suggested by the American Academy of Neurology 1, 2, 4

Botulinum toxin injections are the preferred treatment for focal spasticity affecting specific muscle groups, particularly when causing pain, functional impairment, or compromising positioning and skin care, according to the American Academy of Neurology 1, 2, 3, 4, 5

Intrathecal baclofen via programmable pump delivers medication directly to the spinal cord, requiring only 10% of the systemic dose for equivalent effect, as recommended by the American Academy of Neurology 3, 5
Studies demonstrate that >80% of patients show improvement in muscle tone and >65% have improvement in spasms, according to the American Academy of Neurology 5

Selective dorsal rhizotomy or dorsal root entry zone lesion may be considered for intractable spasticity causing pain, poor skin hygiene, or functional impairment, as suggested by the American Academy of Neurology 1, 2, 3, 4

For focal spasticity, botulinum toxin is strongly preferred over oral baclofen as first-line pharmacological intervention, according to the American Academy of Neurology 5
For generalized spasticity, start with oral baclofen, tizanidine, or dantrolene, and progress to intrathecal baclofen if oral medications fail at maximum tolerated doses, as recommended by the American Academy of Neurology 1, 2, 3, 4, 5

Do not use benzodiazepines during recovery phases, as they impair neurological recovery and cause excessive sedation, according to the American Heart Association 1, 2, 3, 4
Do not abruptly discontinue intrathecal baclofen, as this can be catastrophic and potentially fatal, as warned by the American Academy of Neurology 5
Do not neglect non-pharmacological interventions even when medications are effective, as physical modalities remain essential throughout treatment, according to the American Heart Association 1, 2, 3